Patents by Inventor Wenjing GAO

Wenjing GAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240173353
    Abstract: A cell comprising a mutant protein, the mutant protein causing the cell to be insensitive toward an inhibitor which affects the activity and; or killing function thereof; a universal chimeric antigen receptor T cell which is related to the cell and which is suitable for administration to non-specific patients; and a method for preparing the described cells and an application of the cells in cell therapy.
    Type: Application
    Filed: March 16, 2022
    Publication date: May 30, 2024
    Inventors: Guang HU, Jiayuan ZHANG, Wenjing GAO, Wenjie DONG, Xiaomin YAO, Zhi LIU, Xiaoqian WANG
  • Patent number: 11266690
    Abstract: The invention provides a chimeric antigen receptor (CAR) which can specifically bind to a BCMA protein comprising a BCMA binding structural domain, a transmembrane domain, a costimulatory domain, and an intracellular signaling domain. The invention also provides uses of the CAR in treating diseases or conditions linked to the expression of BCMA.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: March 8, 2022
    Assignees: Nanjing IASO Biotherapeutics Co., Ltd., Innovent Biologics (Suzhou) Co., Ltd.
    Inventors: Jianfeng Zhou, Junjian Liu, Guang Hu, Yongkun Yang, Guangrong Meng, Wenjing Gao, Yuyu Wang, Panpan Niu
  • Patent number: 11026975
    Abstract: The invention provides a chimeric antigen receptor (CAR) which can specifically bind to a BCMA protein comprising a BCMA binding structural domain, a transmembrane domain, a co-stimulatory domain, and an intracellular signaling domain. The invention also provides uses of the CAR in treating diseases or conditions linked to the expression of BCMA.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: June 8, 2021
    Assignees: Nanjing IASO Biotherapeutics Co., Ltd., Innovent Biologics (Suzhou) Co., Ltd.
    Inventors: Jianfeng Zhou, Junjian Liu, Guang Hu, Yongkun Yang, Guangrong Meng, Wenjing Gao, Yuyu Wang, Panpan Niu
  • Publication number: 20200376030
    Abstract: The invention provides a chimeric antigen receptor (CAR) which can specifically bind to a BCMA protein comprising a BCMA binding structural domain, a transmembrane domain, a co-stimulatory domain, and an intracellular signaling domain. The invention also provides uses of the CAR in treating diseases or conditions linked to the expression of BCMA.
    Type: Application
    Filed: January 31, 2019
    Publication date: December 3, 2020
    Inventors: Jianfeng ZHOU, Junjian LIU, Guang HU, Yongkun YANG, Guangrong MENG, Wenjing GAO, Yuyu WANG, Panpan NIU
  • Publication number: 20200246381
    Abstract: The invention provides a chimeric antigen receptor (CAR) which can specifically bind to a BCMA protein comprising a BCMA binding structural domain, a transmembrane domain, a costimulatory domain, and an intracellular signaling domain. The invention also provides uses of the CAR in treating diseases or conditions linked to the expression of BCMA.
    Type: Application
    Filed: January 31, 2019
    Publication date: August 6, 2020
    Inventors: Jianfeng ZHOU, Junjian LIU, Guang HU, Yongkun YANG, Guangrong MENG, Wenjing GAO, Yuyu WANG, Panpan NIU
  • Patent number: D919712
    Type: Grant
    Filed: December 5, 2019
    Date of Patent: May 18, 2021
    Inventor: Wenjing Gao